This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Pharmaceuticalcompanies need to be prepared to answer the call for increased demand and supply into new markets, ensuring the proper resources and logistics framework are in place. Download to learn more. Please check your email to download the Whitepaper.
Challenge Syner-G was contracted by a US PharmaceuticalCompany to help improve the quality of submission documentation generated during the manufacture of a Drug Substance intended for Phase II trials. The progress of the assignment was communicated to the client through weekly reports and regular virtual meetings.
This ensures consistent communication without overburdening your team. downloads, appointment bookings) Email heat maps and click maps These insights help marketers understand which content works, when to send messages, and how to refine future campaigns.
Structuring patient assistance programs as independent non-profit foundations helps pharmaceuticalcompanies reduce regulatory and legal exposure while allowing for more holistic, patient-centered support. Lastly, PAPs that are directly managed by pharmaceuticalcompanies may also struggle with public image issues.
In one of the fierier remarks from the roundtable, RFK Jr said: “At every level, doctors, other providers, our hospitals, the pharmaceuticalcompanies, the insurance companies, all make money by keeping us sick. Please check your inbox to download the Whitepaper. You will receive an email shortly.
Pharmaceuticalcompanies hold permission to market their products directly to consumers. The direct-to-consumer marketing companies for pharmaceuticals are increasingly moving online as it supports the digitisation of information, enabling patients to take control of their health.
Pharmaceutical sales in Brazil reached $17bn in 2021, according to GlobalData figures. Despite this, Brazil’s trade protectionist policies mean that there are few pharmaceuticalcompanies of international origin within the country. Please check your email to download the Whitepaper. by 2040 based on statistics from OECD.
However, Amgen and other pharmaceuticalcompanies have been criticised when they opted to choose the drug’s dosage based on the MTD model, which is commonly used in dose-finding trials. Impact on the industry Veal says that for a lot of pharmaceuticalcompanies there is no “big drive to think about optimizing treatment” post-licensing.
This economic change impacts employment, income, industrial production, and more, and the pharmaceutical industry will not be exempt. While larger, more established pharmaceuticalcompanies may have the infrastructure and financial cushion to fall back on, SMEs need to tread carefully through these economic challenges.
Linking events with the company’s broader content strategy will help regularly communicate more in-depth insights, and delivering content in new and engaging ways, such as gamification or extended reality, will draw in your audience. Dave Yates is a global product director at GSK Pharmaceuticals. About the interviewees.
For the most part, life science companies have a relatively good knowledge of what their audiences want and need from them. Unfortunately, this isn’t always convenient or aligned to the information and tactics they would choose to adopt in their communications. There is clear evidence of a customer-centric paradox. About the author.
GlobalData calculates these risk scores by evaluating several qualitative and quantitative factors to establish the quality of conditions and the level of stability of the market access environment encountered by pharmaceuticalcompanies in each country. Please check your email to download the Report.
To meet these challenges, pharmaceuticalcompanies are accelerating digital transformation and making manufacturing more responsive to changing market conditions while improving efficiency. Moreover, digitalization is increasingly encouraged by regulators as it improves compliance readiness and ensures greater supply chain resiliency.
The download contains detailed information on the providers and their services and solutions, alongside contact details to aid your purchasing or hiring decision. Prospects of clinical dose companies in contract marketing. Prospects of clinical dose companies in contract marketing.
In a highly regulated industry like pharmaceuticals, standing out online can feel like navigating a maze. Unlike retail or tech brands, pharma companies must balance compliance with creativity while communicating with multiple audiences. Unlike paid advertising, SEO delivers sustained, long-term visibility.
Pharmaceutical detailing is the most time-tested marketing format in the medical content world. Old-timer sales reps should remember how pharmaceuticalcompanies reckoned face-to-face (F2F) visits with doctors as the most effective approach to achieving their sales targets. What is Pharmaceutical Detailing?
This could evolve into pharmaceuticalcompanies dealing with semi-permanent higher input costs and other interlinked challenges for longer than current baseline predictions. The magnitude of the hindrance to sales growth and profitability will impact companies from multiple different angles. By GlobalData. United Kingdom.
When paired with AI-based content scoring, pharma teams can now forecast which messages are most likely to drive click-throughs, downloads, or video viewsbefore launching the campaign. Conclusion AI is transforming the way pharmaceuticalcompaniescommunicate, educate, and engage.
If it’s a tight, complicated market, then doctors are going to be looking for the most compelling argument but lot of pharmaceuticalcompanies fall down by not really presenting their product in the best possible light.”. If your team is fully aware of their value, they feel confident communicating with customers. “I
As this trend unfolds, it is vital to understand the benefits 5G brings, how it impacts healthcare communication , and how healthcare businesses can leverage it. 5G represents the 5th generation of cellular technology and is the gold standard in wireless communication today. In this article, we will explore these opportunities.
To reduce the risk of cleanroom contamination, and in collaboration with a leading pharmaceuticalcompany, UV Medico has designed a breakthrough technology: The UV222 Booth. Download White Paper To download this white paper, complete the form below. You may unsubscribe from these ISPE communications at any time.
Pharmaceuticalcompanies and organisations get access to large amounts of data related to patients, clinical trials, and regulatory affairs. The companies help to design, develop and scale marketing strategies to effectively transition into a digitalised future. Please check your email to download the Buyers Guide.
It is also essential to evaluate the reliability of the company supplying the ingredient: do they provide sufficient communication and documentation? Download for a detailed copy of the results. Please check your email to download the Whitepaper. Will they ensure you are notified about any change to the product?
This could evolve into pharmaceuticalcompanies dealing with semi-permanent higher input costs and other interlinked challenges for longer than current baseline predictions. The magnitude of the hindrance to sales growth and profitability will impact companies from multiple different angles. By GlobalData. United Kingdom.
These single-use technologies allow pharmaceuticalcompanies to achieve continuous manufacturing, which significantly reduces the risk of cross-contamination without the need for extensive cleaning and disinfecting. Please check your email to download the Webinar.
Provost added that while it is challenging for pharmaceuticalcompanies to create thermostable vaccines, this creates a severe issue for areas with high ambient temperatures where maintaining a protective cold chain is challenging because of a lack of infrastructure. Please check your email to download the Report.
For many years, the pharmaceutical industry has been accused of overlooking this patient population by instead targeting investments toward more prevalent indications. To read how the team helped one of its partners with the multi-market EU launch, promotion and distribution of a rare disease drug, download the case study below.
According to Baker Mackenzie , a law firm brand that specialises in a range of industries including healthcare and life sciences, IPOs allow pharmaceuticalcompanies to “access major global finance hubs and capital from a deep pool of investors around the world”. Please check your email to download the Report.
Celnova Pharma is an Argentina-based pharmaceuticalcompany that centres its work around rare diseases, oncology, central nervous system, diabetes and critical care. The company currently has operations in Argentina, Colombia, Chile, Peru, and Uruguay. Please check your email to download the Report.
Considering the high price points of ATMPs, this is a clear benefit for buyers and a potential downside for pharmaceuticalcompanies. Abacus Medicine Pharma Services (AMPS) is a strategic partner to pharmaceuticalcompanies launching and distributing medicines in Europe.
To keep within this limit, pharmaceuticalcompanies have had to pay rebates on their sales back to the NHS on all expenditures above the capped limit. Companies that choose not to take part in the voluntary scheme must partake in a statutory scheme. Please check your email to download the Report.
With better patient engagement having been proven to result in better health outcomes and reduced dropout rates, sponsors are increasingly recognising the vital importance of enrolling the right patients and communicating with them effectively. Please check your email to download the Whitepaper.
Biostar Pharma chairman Dr Li Tang said this study approval was a milestone in the UTD1’s global development, and expressed an interest in partnering with other pharmaceuticalcompanies to bring the treatment to market. Download the full report to understand what to expect and how to align your strategies for success.
With a customised ERP system, a bespoke global distribution centre and a leadership team with decades of experience, AMPS is evolving into the next-generation healthcare and pharma services company by combining the infrastructure and skills at Abacus Medicine with the experience and expertise within AMPS.
Explaining the rise of HPAPIs, Bruno Villa, CEO, MEDELPHARM believes the trend is a consequence of the increasing pressure on pharmaceuticalcompanies to develop drugs with improved efficiency and efficacy. To learn more about containment, download the whitepaper below. Please check your email to download the Whitepaper.
Generic and biosimilar pharmaceuticalcompany and Novartis subsidiary Sandoz announced its plan to accelerate patient access to biosimilars. Download the full report to understand what to expect and how to align your strategies for success. Please check your email to download the Report.
This latest disagreement is another chapter in the ongoing debate between regulators and pharmaceuticalcompanies over ALS trial endpoints. Download the full report to understand what to expect and how to align your strategies for success. Please check your email to download the Report.
Pharmaceuticalcompany Genmab is entering a partnership with argenx to develop antibody therapies for oncology and immunology. This collaboration is being made to combine the companies’ capabilities to develop novel therapeutic antibodies with applications in the two disease areas. Evaluate the effects of COVID-19 on the sector.
This guidance has driven many pharmaceuticalcompanies to revaluate their approach to CCIT. According to Lukas Engel, market manager pharma CCIT at Pfeiffer Vacuum, companies are increasingly looking to perform high throughput testing with sophisticated, deterministic methods. Please check your email to download the Whitepaper.
As pharmaceuticalcompanies launch their products across European countries, the joint procedure is intended to reduce the duplication of submissions with different evidence requirements and procedural times required at a country level, and thus streamline workflows and reduce administrative burden. By Abacus Medicine Pharma Services.
Beyond that, eConsent can integrate into a broader digital ecosystem, which unlocks valuable opportunities for automation, cost reducion and time savings, Balcerzak explains: “For pharmaceuticalcompanies, eConsent lowers their risk because they can educate the patient better and ulimately retain the patient throughout the trial process.
Of the world’s 20 largest pharmaceuticalcompanies, 17 have launched programmes tailored towards increasing medication access in low- and middle-income countries – up from just eight in 2010. Figure 1: Social media posts from pharmaceutical firms mentioning “environment”. A similar theme is evident in company filings.
PAT, used correctly, should lead to better manufacturing processes and ultimately significant business benefits for the pharmaceuticalcompany. For more information download the paper below. Please check your email to download the Whitepaper.
The CLR is a great option for pharmaceuticalcompanies performing steam sterilisation in the drying chamber. This also gives us a bigger picture of the process and a deeper knowledge compared to other companies who maybe only provide a particular component to this application,” believes Kuchenbecker.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content